Market Research Logo

UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review

UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review

-provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

UniQure NV (UniQure), formerly uniQure BV is a pharmaceutical company that develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies by using its modular technology platform. Its glybera is used to restore the LPL enzyme activity. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia B, sanfilippo B syndrome, acute intermittent porphyria, congestive heart failure and Parkinson’s disease. The company develops a modular platform to bring new disease modifying therapies to patients with genetic diseases. It provides clinical proof-of-concept in hemophilia B, and preclinical Huntington’s disease. UniQure also develops gene therapies for cardiovascular diseases. The company conducts drug discovery and preclinical research in collaboration with academic research institutions. It also develops its gene therapies using a modular technology platform. UniQure is headquartered in Amsterdam, the Netherlands.

UniQure NV Key Recent Developments

Nov 01,2017: uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress
Oct 31,2017: uniQure Announces Multiple Company Presentations at Upcoming November Conferences
Oct 02,2017: uniQure Announces Company Presentations at Upcoming October Conferences
Aug 08,2017: uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress
Aug 07,2017: uniQure Announces Leadership Team Appointments and Nominations to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
UniQure NV - Key Facts
UniQure NV - Key Employees
UniQure NV - Major Products and Services
UniQure NV - History
UniQure NV - Company Statement
UniQure NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
UniQure NV - Business Description
UniQure NV - Corporate Strategy
UniQure NV - SWOT Analysis
SWOT Analysis - Overview
UniQure NV - Strengths
UniQure NV - Weaknesses
UniQure NV - Opportunities
UniQure NV - Threats
UniQure NV - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
UniQure NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
UniQure NV, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
UniQure NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 01, 2017: uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress
Oct 31, 2017: uniQure Announces Multiple Company Presentations at Upcoming November Conferences
Oct 02, 2017: uniQure Announces Company Presentations at Upcoming October Conferences
Aug 08, 2017: uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress
Aug 07, 2017: uniQure Announces Leadership Team Appointments and Nominations to its Board of Directors
Jul 18, 2017: uniQure Expands Intellectual Property Portfolio with Newly Issued Patent Providing Broad Protection of Insect Cell-Based AAV Manufacturing
Jun 15, 2017: uniQure Publishes Data Further Demonstrating Favorable Immunogenicity Profile and Broad Utilization of AAV5-Based Gene Therapies
Jun 06, 2017: uniQure Announces Appointment of Steven L. Zelenkofske as Chief Medical Officer
May 11, 2017: uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates
May 09, 2017: uniQure Announces First Quarter 2017 Financial Results and Highlights Recent Company Progress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
UniQure NV, Key Facts
UniQure NV, Key Employees
UniQure NV, Major Products and Services
UniQure NV, History
UniQure NV, Subsidiaries
UniQure NV, Key Competitors
UniQure NV, Ratios based on current share price
UniQure NV, Annual Ratios
UniQure NV, Annual Ratios (Cont...1)
UniQure NV, Interim Ratios
UniQure NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
UniQure NV, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
UniQure NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
UniQure NV, Performance Chart (2012 - 2016)
UniQure NV, Ratio Charts
UniQure NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
UniQure NV, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report